ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Austin, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Breast Cancer
Cancer
Ovarian Cancer
Neoplasm Metastasis
Non-Small-Cell Lung Carcinoma
Colorectal Cancer

Prostate Cancer trials near Austin, TX, USA:

WATER IV Prostate Cancer (WATER IV PCa)

Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for, or have opted for, pros...

Active, not recruiting
Localized Prostate Cancer
Device: Aquablation Therapy
Procedure: Radical Prostatectomy
PROCEPT BioRobotics

Austin, Texas, United States and 38 other locations

Assessment of the safety and efficacy of HLD-0915 (JNJ-101556143) in patients with metastatic prostate cancer who have progressed o ...

Enrolling
Metastatic Prostate Cancer
Drug: JNJ-101556143 Formulation 1
Drug: JNJ-101556143 Formulation 3

Phase 1, Phase 2

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

Austin, Texas, United States and 17 other locations

radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stim...

Active, not recruiting
Prostate Cancer
Biological: Placebo + valacyclovir
Biological: Aglatimagene besadenovec + valacyclovir

Phase 3

Candel Therapeutics

Austin, Texas, United States and 72 other locations

multicenter, prospective, randomized clinical trial that aims to evaluate the safety and efficacy of Aquablation therapy in men with localized prostate...

Begins enrollment this month
Localized Prostate Cancer
Device: Aquablation Therapy
Other: Active Surveillance
PROCEPT BioRobotics

Austin, Texas, United States and 24 other locations

with high-risk and very high-risk localised/locally advanced prostate cancer with a breast cancer gene mutation (BRCAm)....

Enrolling
Prostate Cancer
Drug: Saruparib
Drug: Abiraterone + Prednisolone/Prednisone

Phase 3

AstraZeneca
AstraZeneca

Austin, Texas, United States and 345 other locations

of the Vanquish Water Vapor Ablation Device ("Vanquish") in treating subjects with Gleason Grade Group 2 (GGG2) localized intermediate-risk prostate...

Active, not recruiting
Prostate Cancer
Device: Vanquish System
Francis Medical

Austin, Texas, United States and 24 other locations

plus docetaxel in participants with metastatic castration resistant prostate cancer (mCRPC), all participants will receive the doce...

Active, not recruiting
Prostate Cancer
Other: placebo
Drug: capivasertib

Phase 3

AstraZeneca
AstraZeneca

Austin, Texas, United States and 216 other locations

compare the efficacy and safety of BMS-986365 versus the investigator's choice of therapy in participants with Metastatic Castration-resistant Prostate...

Enrolling
Metastatic Castration-resistant Prostate Cancer
Drug: Docetaxel
Drug: Abiraterone

Phase 3

Celgene
Celgene

Austin, Texas, United States and 282 other locations

prior abiraterone defined as:* Abiraterone started in hormone-sensitive prostate cancer (HSPC) disease setting: \< 12 months durat ...

Enrolling
Metastatic Castration-Resistant Prostate Cancer
Drug: ZEN003694
Drug: Enzalutamide

Phase 2

Zenith Epigenetics

Austin, Texas, United States and 30 other locations

for the possible treatment of Relapsed/ Refractory Small Cell Lung Cancer (SCLC), Castration Resistant Prostate Cancer (CR...

Enrolling
Metastatic Castration Resistant Prostate Cancer (mCRPC)
Small Cell Lung Cancer (SCLC)
Drug: Mervometostat (PF-06821497)
Drug: Enzalutamide

Phase 1

Pfizer
Pfizer

Austin, Texas, United States and 85 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems